Punctate palmoplantar keratoderma type 1: a novel AAGAB mutation and efficacy of etretinate

Acta Derm Venereol. 2015 Jan;95(1):110-1. doi: 10.2340/00015555-1832.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Vesicular Transport / genetics*
  • Aged, 80 and over
  • Biopsy
  • DNA Mutational Analysis
  • Etretinate / therapeutic use*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Immunohistochemistry
  • Keratoderma, Palmoplantar / diagnosis
  • Keratoderma, Palmoplantar / drug therapy*
  • Keratoderma, Palmoplantar / genetics*
  • Keratolytic Agents / therapeutic use*
  • Mutation*
  • Phenotype
  • Remission Induction
  • Treatment Outcome

Substances

  • AAGAB protein, human
  • Adaptor Proteins, Vesicular Transport
  • Keratolytic Agents
  • Etretinate

Supplementary concepts

  • Keratosis palmoplantaris papulosa